{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:15:52Z","timestamp":1791825352927,"version":"4.3.4"},"reference-count":49,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T00:00:00Z","timestamp":1607126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Muscle and Nerve"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>The Duke Myasthenia Gravis (MG) Clinic Registry is a disease\u2010specific database containing physician\u2010derived data from patients seen in the Duke MG Clinic since 1980.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data from 1060 MG patients initially seen between 1980 and 2008 were reviewed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fifty\u2010four percent were male. Symptoms began after age 50 in 66% of males and 42% of females. Peak onset age in males was in their 60's; females had no predominant onset age. Onset age for both sexes increased from 1980 to 2008. Thymoma was present in 8.5%. Weakness was limited to ocular muscles for at least 2 y in 22% and became generalized later in 8.3% of these. Acetylcholine receptor antibodies were present in 78% overall, 82% with generalized MG and 52% with ocular MG (OMG). The distribution of MG disease class was similar in males and females, except that a greater proportion of women experienced myasthenic crisis and men were more likely to have OMG.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Data in the Registry permit comprehensive and longitudinal analysis of a validated MG population. Analysis of Registry data shows that the frequency of AChR antibody negative MG, ocular MG, and thymoma are similar to other reports, but the onset age and proportion of males have progressively increased compared to studies published more than 20\u2009y ago. These observations demonstrate the value of collecting comprehensive clinical information and comparing historic and contemporary populations. Other potential uses of Registry data include comparison of outcome measures in different disease subgroups and the response to specific treatments.<\/jats:p><\/jats:sec>","DOI":"10.1002\/mus.27120","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T07:06:55Z","timestamp":1605683215000},"page":"209-216","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The <scp>D<\/scp>uke myasthenia gravis clinic registry: <scp>I<\/scp>. <scp>D<\/scp>escription and demographics"],"prefix":"10.1002","volume":"63","author":[{"given":"Donald B.","family":"Sanders","sequence":"first","affiliation":[{"name":"Neuromuscular Division, Department of Neurology Duke University Medical Center  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0216-1564","authenticated-orcid":false,"given":"Shruti M.","family":"Raja","sequence":"additional","affiliation":[{"name":"Neuromuscular Division, Department of Neurology Duke University Medical Center  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey T.","family":"Guptill","sequence":"additional","affiliation":[{"name":"Neuromuscular Division, Department of Neurology Duke University Medical Center  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa D.","family":"Hobson\u2010Webb","sequence":"additional","affiliation":[{"name":"Neuromuscular Division, Department of Neurology Duke University Medical Center  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vern C.","family":"Juel","sequence":"additional","affiliation":[{"name":"Neuromuscular Division, Department of Neurology Duke University Medical Center  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice M.","family":"Massey","sequence":"additional","affiliation":[{"name":"Neuromuscular Division, Department of Neurology Duke University Medical Center  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,12,5]]},"reference":[{"key":"e_1_2_10_2_1","first-page":"381","article-title":"The Duke MG clinic registry \u2010 a disease\u2010specific database program","volume":"1132","author":"Sanders DB","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"e_1_2_10_3_1","unstructured":"NINDS Common Data Elements: Myasthenia Gravis.2020.https:\/\/www.commondataelements.ninds.nih.gov\/Myasthenia%20Gravis()."},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.Suppl_5.40S"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23944"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25440"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23882"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24694"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21883"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000312373.67493.7f"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000312374.95186.cc"},{"issue":"1","key":"e_1_2_10_12_1","first-page":"A107","article-title":"A trial of mycophenolate mofetil (MMF) with prednisone as initial immunotherapy in myasthenia gravis (MG)","volume":"68","author":"Sanders DB","year":"2007","journal-title":"Neurology"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006478"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13563"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.04.002"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-012-6478-6"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.1.16"},{"key":"e_1_2_10_18_1","unstructured":"Statistics With Confidence.London: BMJ Books;2000."},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880050409"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.28.8.847"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.54.5.452"},{"key":"e_1_2_10_22_1","volume-title":"Registries for Evaluating Patient Outcomes: A User's Guide. 2nd Ed. AHRQ Publication No10\u2010EHC049","author":"Gliklich RE","year":"2010"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.16.5.431"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1981.tb33764.x"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1987.tb51317.x"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20950"},{"key":"e_1_2_10_27_1","first-page":"497","article-title":"Studies in myasthenia gravis: review of a 20\u2010year experience in over 1200 patients","volume":"38","author":"Osserman KE","year":"1971","journal-title":"Mt Sinai J Med"},{"key":"e_1_2_10_28_1","volume-title":"Myasthenia Gravis","author":"Oosterhuis HJGH","year":"1997"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1254.054"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.3109\/08916930903518107"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2012.06771.x"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.10.1888"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318217e735"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000176067.32186.a3"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.44.572"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008903"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1159\/000500268"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.2.243"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5120-8"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.48.12.1246"},{"key":"e_1_2_10_41_1","first-page":"257","article-title":"Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles","volume":"49","author":"Vincent A","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2006.05.006"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20854"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(03)00306-5"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000065882.63904.53"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20061"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2008.05.032"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.6.1002"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.51.8196"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116830"}],"container-title":["Muscle &amp; Nerve"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mus.27120","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/mus.27120","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mus.27120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T08:52:10Z","timestamp":1693558330000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mus.27120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,5]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1002\/mus.27120"],"URL":"https:\/\/doi.org\/10.1002\/mus.27120","archive":["Portico"],"relation":{},"ISSN":["0148-639X","1097-4598"],"issn-type":[{"value":"0148-639X","type":"print"},{"value":"1097-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,5]]},"assertion":[{"value":"2020-07-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}